Also found in: Dictionary, Medical.
Related to Embryopathy: teratogenic, rubella embryopathy


Any abnormal development of an embryo, either morphological or biochemical.



a disease of or injury to a human embryo occurring between the middle of the first and the end of the third month of intrauterine development. Embryopathy may be caused by a genetic disturbance or by a pathogenic factor that affects the embryo through the mother, such as hypoxia, poisoning, or an infectious disease. Embryopathy may result in malformation of embryonic organs, developmental anomalies, and spontaneous abortion. Prevention calls for the protection of the mother’s health during the first months of pregnancy.

Mentioned in ?
References in periodicals archive ?
The second step of the evaluation circuit of Thalidomide will be that the Diagnostic Units receive this request and, once in their hands, they will analyze whether the cases are compatible with the thalidomide embryopathy, writing an interim report that will be posted for this purpose.
Schuler-Faccini L, Ribeiro EM, Feitosa IM, Horovitz DD, Cavalcanti DP, Pessoa A, Doriqui MJ, Neri JI, Neto JM, Wanderley HY, Cernach M, El-Husny AS, Pone MV, Serao CL, Sanseverino MT, Brazilian Medical Genetics Society-Zika Embryopathy Task Force.
This results in a 4-10% risk of warfarin embryopathy (Table 5).
6) Many authors have also suggested hereditary involvement as an autosomal dominant trait with reduced penetrance, trauma and environmental factors such as thalidomide, embryopathy, fetal alcohol exposure or hypervitaminosis.
Retinoid embryopathy ranges from craniofacial dysmorphias appendagial abnormalities to meningoencephaloceles.
These types of malformations have been grouped in a fairly specific embryopathy called fetal valproate syndrome.
Septo-optic dysplasia as a manifestation of valproic acid embryopathy.
AMP-activated protein kinase mediates effects of oxidative stress on embryo gene expression in a mouse model of diabetic embryopathy.
Neuropathy to embryopathy, with case reports of congenital anomalies.
Reporting bias in retrospective ascertainment of drug induced embryopathy.
A case of methotrexate embryopathy with holoprosencephaly, expanding the phenotype.
The chief risk posed by use of the drug in women of childbearing potential is retinoid embryopathy, which occurs in 33% of preterm infants exposed to the drug in utero.